Fulton Breakefield Broenniman’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.04M | Sell |
5,785
-97
| -2% | -$34.6K | 0.13% | 76 |
|
|
2025
Q4 | $1.93M | Sell |
5,882
-47
| -0.8% | -$14.9K | 0.12% | 75 |
|
|
2025
Q3 | $1.67M | Buy |
5,929
+88
| +2% | +$25.5K | 0.11% | 81 |
|
|
2025
Q2 | $1.63M | Buy |
5,841
+55
| +1% | +$15.6K | 0.11% | 80 |
|
|
2025
Q1 | $1.8M | Buy |
5,786
+1
| +0% | +$295 | 0.13% | 75 |
|
|
2024
Q4 | $1.51M | Sell |
5,785
-14
| -0.2% | -$4.15K | 0.11% | 84 |
|
|
2024
Q3 | $1.87M | Sell |
5,799
-680
| -10% | -$222K | 0.13% | 78 |
|
|
2024
Q2 | $2.02M | Buy |
6,479
+76
| +1% | +$22.3K | 0.15% | 71 |
|
|
2024
Q1 | $1.82M | Sell |
6,403
-910
| -12% | -$266K | 0.14% | 73 |
|
|
2023
Q4 | $2.11M | Sell |
7,313
-821
| -10% | -$224K | 0.17% | 65 |
|
|
2023
Q3 | $2.19M | Sell |
8,134
-143
| -2% | -$35.7K | 0.19% | 68 |
|
|
2023
Q2 | $1.84M | Hold |
8,277
| – | – | 0.15% | 71 |
|
|
2023
Q1 | $2M | Sell |
8,277
-28
| -0.3% | -$6.87K | 0.17% | 72 |
|
|
2022
Q4 | $2.18M | Buy |
8,305
+1,160
| +16% | +$311K | 0.19% | 70 |
|
|
2022
Q3 | $1.61M | Sell |
7,145
-181
| -2% | -$43.9K | 0.15% | 72 |
|
|
2022
Q2 | $1.78M | Buy |
+7,326
| New | +$1.8M | 0.15% | 76 |
|
|
2022
Q1 | – | Sell |
-8,353
| Closed | -$1.88M | – | 166 |
|
|
2021
Q4 | $1.88M | Buy |
8,353
+1,855
| +29% | +$392K | 0.14% | 76 |
|
|
2021
Q3 | $1.38M | Sell |
6,498
-278
| -4% | -$64K | 0.12% | 74 |
|
|
2021
Q2 | $1.65M | Buy |
6,776
+51
| +0.8% | +$12.5K | 0.14% | 72 |
|
|
2021
Q1 | $1.67M | Buy |
6,725
+714
| +12% | +$170K | 0.15% | 70 |
|
|
2020
Q4 | $1.38M | Sell |
6,011
-852
| -12% | -$196K | 0.17% | 67 |
|
|
2020
Q3 | $1.74M | Sell |
6,863
-155
| -2% | -$38.4K | 0.2% | 62 |
|
|
2020
Q2 | $1.66M | Hold |
7,018
| – | – | 0.2% | 62 |
|
|
2020
Q1 | $1.42M | Sell |
7,018
-477
| -6% | -$104K | 0.21% | 61 |
|
|
2019
Q4 | $1.81M | Sell |
7,495
-152
| -2% | -$33.5K | 0.21% | 72 |
|
|
2019
Q3 | $1.48M | Buy |
+7,647
| New | +$1.47M | 0.19% | 75 |
|
|
2019
Q1 | – | Sell |
-14,415
| Closed | -$2.81M | – | 102 |
|
|
2018
Q4 | $2.81M | Sell |
14,415
-1,177
| -8% | -$230K | 0.5% | 59 |
|
|
2018
Q3 | $3.23M | Sell |
15,592
-800
| -5% | -$158K | 0.5% | 61 |
|
|
2018
Q2 | $3.03M | Sell |
16,392
-23,912
| -59% | -$4.23M | 0.48% | 66 |
|
|
2018
Q1 | $6.87M | Sell |
40,304
-18
| -0% | -$3.3K | 1.19% | 45 |
|
|
2017
Q4 | $7.01M | Buy |
40,322
+134
| +0.3% | +$23.7K | 1.18% | 42 |
|
|
2017
Q3 | $7.49M | Sell |
40,188
-1
| -0% | -$177 | 1.31% | 33 |
|
|
2017
Q2 | $6.92M | Sell |
40,189
-79
| -0.2% | -$12.8K | 1.24% | 39 |
|
|
2017
Q1 | $6.61M | Buy |
40,268
+1,204
| +3% | +$200K | 1.23% | 37 |
|
|
2016
Q4 | $5.71M | Sell |
39,064
-890
| -2% | -$134K | 1.13% | 40 |
|
|
2016
Q3 | $6.67M | Sell |
39,954
-895
| -2% | -$151K | 1.35% | 34 |
|
|
2016
Q2 | $6.21M | Buy |
40,849
+162
| +0.4% | +$25.2K | 1.27% | 35 |
|
|
2016
Q1 | $6.1M | Buy |
40,687
+1,749
| +4% | +$260K | 1.34% | 32 |
|
|
2015
Q4 | $6.32M | Buy |
38,938
+302
| +0.8% | +$47.5K | 1.4% | 28 |
|
|
2015
Q3 | $5.34M | Sell |
38,636
-4,403
| -10% | -$694K | 1.26% | 35 |
|
|
2015
Q2 | $6.61M | Buy |
43,039
+1,131
| +3% | +$181K | 1.45% | 26 |
|
|
2015
Q1 | $6.7M | Buy |
41,908
+925
| +2% | +$146K | 1.49% | 25 |
|
|
2014
Q4 | $6.53M | Buy |
40,983
+236
| +0.6% | +$36.8K | 1.43% | 27 |
|
|
2014
Q3 | $5.72M | Buy |
40,747
+32
| +0.1% | +$4.18K | 1.34% | 34 |
|
|
2014
Q2 | $4.82M | Sell |
40,715
-64
| -0.2% | -$7.41K | 1.17% | 36 |
|
|
2014
Q1 | $5.03M | Buy |
40,779
+642
| +2% | +$77.9K | 1.3% | 32 |
|
|
2013
Q4 | $4.58M | Sell |
40,137
-2,289
| -5% | -$260K | 1.21% | 31 |
|
|
2013
Q3 | $4.75M | Buy |
42,426
+1,242
| +3% | +$135K | 1.28% | 29 |
|
|
2013
Q2 | $4.06M | Buy |
+41,184
| New | +$4.27M | 1.19% | 32 |
|
Other funds holding AMGN
VCM
VPM
Fulton Breakefield Broenniman's AMGN Position: Q1 2026 in Review
Fulton Breakefield Broenniman reduced its Amgen (AMGN) stake by 1.6% in Q1 2026, selling an estimated $34.6K and leaving 5,785 shares worth $2.04M. The position accounts for 0.13% of the portfolio, ranked #76.
Fulton Breakefield Broenniman first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $7.49M in Q3 2017. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Fulton Breakefield Broenniman held 5,785 shares of Amgen worth $2.04M as of Q1 2026.
- Fulton Breakefield Broenniman sold 97 Amgen shares in Q1 2026, an estimated $34.6K.
- Amgen made up 0.13% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #76 holding.
- Fulton Breakefield Broenniman first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
- Fulton Breakefield Broenniman's Amgen position peaked at $7.49M in Q3 2017.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.